About Schrodinger
Schrödinger is a computational platform company that transforms the way therapeutics and materials are discovered through physics-based molecular modeling and simulation. Founded over 30 years ago, the company has built an industry-leading software platform that combines advanced computational chemistry, molecular dynamics, machine learning, and predictive modeling to accelerate molecular discovery across life sciences and materials science applications. The company's flagship products include Maestro (unified modeling environment), Glide (ligand-receptor docking), FEP+ (free energy calculations), LiveDesign (collaborative design platform), Desmond (molecular dynamics), and Jaguar (quantum chemistry). These tools enable computational chemists, medicinal chemists, and materials scientists to predict molecular properties, optimize drug candidates, and design novel materials with greater speed and accuracy than traditional experimental methods alone. Schrödinger serves a diverse customer base spanning biotech and pharmaceutical companies, academic institutions, and materials science organizations across aerospace, automotive, consumer packaged goods, semiconductors, and specialty chemicals industries. The company's technology addresses critical challenges in small molecule drug discovery, antibody design, peptide discovery, enzyme engineering, drug formulation, polymeric materials, organic electronics, catalysis, and pharmaceutical formulations. Beyond its software business, Schrödinger operates its own therapeutics discovery group that leverages the platform to advance a proprietary pipeline of drug candidates. Current clinical programs include SGR-1505, a MALT1 inhibitor that has received Fast Track designation for relapsed/refractory Waldenström Macroglobulinemia, and SGR-3515, a Wee1/Myt1 inhibitor. The company's mission is to improve human health and quality of life by transforming therapeutic and materials discovery through computational innovation.
Mission & Story
Mission
Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered.
Clinical Focus
Medical conditions and clinical areas addressed by Schrodinger.
Who It Serves
Milestones & Awards
Recent Milestones
SGR-1505 received Fast Track designation; Phase 1 clinical data for SGR-1505 presented at EHA Annual Congress; Multiple inducement grants reported under Nasdaq rules in 2026
Awards & Recognition
Industry-leading docking solution (Glide); 30+ years as established computational chemistry platform
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.